CRTHF (CARsgen Therapeutics Holdings) FCF Yield %: -3.15 (As of Jul. 08, 2026)


CRTHF CARsgen Therapeutics Holdings Ltd CRTHF
24 GF Score
Price $2.08
! 3 Warning Signs
View Full Analysis

What is CARsgen Therapeutics Holdings FCF Yield %?

CARsgen Therapeutics Holdings CRTHF 24 FCF Yield % is -3.15 as of Jul. 08, 2026. GuruFocus rates CRTHF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 1,406 Biotechnology companies, CARsgen Therapeutics Holdings ranks better than 70.13% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, CARsgen Therapeutics Holdings's Trailing 12-Month Free Cash Flow is $-33.97 Mil, and Market Cap is $1,113.23 Mil. Therefore, CARsgen Therapeutics Holdings's FCF Yield % for today is -3.15%.

The historical rank and industry rank for CARsgen Therapeutics Holdings's FCF Yield % or its related term are showing as below:

CRTHF' s FCF Yield % Range Over the Past 10 Years
Min: -81.59   Med: -15.08   Max: -1.95
Current: -3.15

During the past 7 years, the highest FCF Yield % of CARsgen Therapeutics Holdings was -1.95%. The lowest was -81.59%. And the median was -15.08%.

CRTHF's FCF Yield % is ranked better than
70.13% of 1406 companies
in the Biotechnology industry
Industry Median: -9.28 vs CRTHF: -3.15

CARsgen Therapeutics Holdings's FCF Margin % for the quarter that ended in Dec. 2025 was -58.86%.

CARsgen Therapeutics Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

CARsgen Therapeutics Holdings FCF Yield % Related Terms

CARsgen Therapeutics Holdings FCF Yield % Historical Data

* Premium members only.

The historical data trend for CARsgen Therapeutics Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARsgen Therapeutics Holdings FCF Yield % Chart

CARsgen Therapeutics Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial 0.00 -10.86 -6.99 -14.12 -3.62

CARsgen Therapeutics Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.44 -17.29 -11.03 -13.17 -1.31

CRTHF vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, CARsgen Therapeutics Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CARsgen Therapeutics Holdings FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where CARsgen Therapeutics Holdings's FCF Yield % falls into.


CRTHF
24GF Score
CARsgen Therapeutics Holdings Ltd CRTHF
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARsgen Therapeutics Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

CARsgen Therapeutics Holdings's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-34.505 / 952.7180152
=-3.62%

CARsgen Therapeutics Holdings's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.243 * 2 / 952.7180152
=-1.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -3.15 mean?
CARsgen Therapeutics Holdings (CRTHF) has a FCF Yield % of -3.15 as of Jul. 08, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on CARsgen Therapeutics Holdings and its competitors. According to the industry distribution chart, CARsgen Therapeutics Holdings ranks #420 out of 1406 companies in the Biotechnology industry, placing it in the top 29.9%.
Is CARsgen Therapeutics Holdings' FCF Yield % too high?
CARsgen Therapeutics Holdings' current FCF Yield % is -3.15. Based on the distribution chart, CARsgen Therapeutics Holdings ranks #420 out of 1406 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CARsgen Therapeutics Holdings has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does CARsgen Therapeutics Holdings' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CARsgen Therapeutics Holdings ranks #420 out of 1406 companies for FCF Yield %. This puts CARsgen Therapeutics Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on CARsgen Therapeutics Holdings and its competitors. CARsgen Therapeutics Holdings's current FCF Yield % is -3.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARsgen Therapeutics Holdings stock overvalued right now?
CARsgen Therapeutics Holdings (CRTHF) has a current FCF Yield % of -3.15. The current FCF Yield % is -3.15. CARsgen Therapeutics Holdings' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For CARsgen Therapeutics Holdings (CRTHF), the current FCF Yield % is -3.15 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CARsgen Therapeutics Holdings Business Description

Other Exchanges 02171:Hong Kong
Address No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
24GF Score

Get the complete analysis for CRTHF

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.08
Price